"Lipoproteins, HDL" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of lipoproteins of small size (4-13 nm) and dense (greater than 1.063 g/ml) particles. HDL lipoproteins, synthesized in the liver without a lipid core, accumulate cholesterol esters from peripheral tissues and transport them to the liver for re-utilization or elimination from the body (the reverse cholesterol transport). Their major protein component is APOLIPOPROTEIN A-I. HDL also shuttle APOLIPOPROTEINS C and APOLIPOPROTEINS E to and from triglyceride-rich lipoproteins during their catabolism. HDL plasma level has been inversely correlated with the risk of cardiovascular diseases.
MeSH Number(s)
D10.532.432
D12.776.521.479
Concept/Terms
Lipoproteins, HDL- Lipoproteins, HDL
- HDL Lipoproteins
- Heavy Lipoproteins
- Lipoproteins, Heavy
- High-Density Lipoproteins
- High Density Lipoproteins
- Lipoproteins, High-Density
- alpha-Lipoproteins
- alpha Lipoproteins
Below are MeSH descriptors whose meaning is more general than "Lipoproteins, HDL".
Below are MeSH descriptors whose meaning is more specific than "Lipoproteins, HDL".
This graph shows the total number of publications written about "Lipoproteins, HDL" by people in Harvard Catalyst Profiles by year, and whether "Lipoproteins, HDL" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 2 | 1 | 3 |
1996 | 2 | 2 | 4 |
1997 | 3 | 2 | 5 |
1998 | 1 | 3 | 4 |
1999 | 1 | 1 | 2 |
2000 | 0 | 4 | 4 |
2002 | 3 | 3 | 6 |
2003 | 0 | 5 | 5 |
2004 | 1 | 5 | 6 |
2005 | 6 | 4 | 10 |
2006 | 6 | 9 | 15 |
2007 | 12 | 4 | 16 |
2008 | 6 | 2 | 8 |
2009 | 3 | 5 | 8 |
2010 | 10 | 10 | 20 |
2011 | 11 | 7 | 18 |
2012 | 9 | 4 | 13 |
2013 | 19 | 6 | 25 |
2014 | 12 | 12 | 24 |
2015 | 17 | 3 | 20 |
2016 | 19 | 11 | 30 |
2017 | 11 | 8 | 19 |
2018 | 11 | 5 | 16 |
2019 | 9 | 9 | 18 |
2020 | 7 | 5 | 12 |
2021 | 6 | 6 | 12 |
2022 | 2 | 11 | 13 |
2023 | 0 | 8 | 8 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Lipoproteins, HDL" by people in Profiles.
-
Designer high-density lipoprotein particles enhance endothelial barrier function and suppress inflammation. Sci Signal. 2024 Feb 20; 17(824):eadg9256.
-
Understanding HDL Metabolism and Biology Through In Vivo Tracer Kinetics. Arterioscler Thromb Vasc Biol. 2024 01; 44(1):76-88.
-
Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. J Am Heart Assoc. 2023 11 07; 12(21):e031160.
-
Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the CETP Gene. J Am Heart Assoc. 2023 11 07; 12(21):e031459.
-
Proteomic Determinants of Variation in Cholesterol Efflux: Observations from the Dallas Heart Study. Int J Mol Sci. 2023 Oct 24; 24(21).
-
High-density lipoprotein functionality, cardiovascular health, and patterns of alcohol consumption: new insights and future perspectives. Curr Opin Lipidol. 2024 Feb 01; 35(1):25-32.
-
Data-driven phenomapping for novel classification for cardiovascular outcomes compared with traditional obesity index: Tehran Lipid and Glucose Study. BMJ Open. 2023 06 14; 13(6):e071011.
-
Biological basis and proposed mechanism of action of CSL112 (apolipoprotein A-I [human]) for prevention of major adverse cardiovascular events in patients with myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2023 06 02; 9(4):387-398.
-
Therapeutic activation of endothelial sphingosine-1-phosphate receptor 1 by chaperone-bound S1P suppresses proliferative retinal neovascularization. EMBO Mol Med. 2023 05 08; 15(5):e16645.
-
Lipoprotein Subclasses Associated With High-Risk Coronary Atherosclerotic Plaque: Insights From the PROMISE Clinical Trial. J Am Heart Assoc. 2023 01 03; 12(1):e026662.